Business
Health Canada Approves (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide) Triple-Combination Topical Treatment for Acne Vulgaris in Patients 12 Years of Age and Older
LAVAL, QC / ACCESSWIRE / September 11, 2024 / Bausch Health, Canada Inc., part of Bausch Health ...
About this update from Bausch Health Companies Inc.
[{"type":"text","content":"Health Canada Approves (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide) Triple-Combination Topical Treatment for Acne Vulgaris in Patients 12 Years of Age and OlderLAVAL, QC / ACCESSWIRE / September 11, 2024 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced the approval by Health Canada of PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel 1.2%/0.15%/3.1%, a new triple-combination topical prescription treatment for acne vulgaris in patients 12 years of age and older.1CABTREO is the first and only triple-combination topical treatment for acne approved by Health Canada with three mechanisms of action - an antibiotic, a retinoid and an antibacterial agent - to provide a safe and effective treatment.1\"The approval of CABTREO shows the continuing commitment of Bausch Health to bring innovative dermatology treatments to Canadians,\" said Amy Cairns, Vice-President, Commercial and General Manager, Canada, Bausch Health. \"We are proud to offer this first triple-combination topical acne treatment to millions of Canadians who suffer from acne each year.\"CABTREO is a topical gel that is administered by patients once daily to affected areas of their skin. Its active ingredients are the antibiotic clindamycin phosphate, the topical retinoid adapalene, and the oxidizing agent benzoyl peroxide which has a broad-spectrum anti-bacterial activity.1\"The unique triple combination provided by CABTREO has shown significant treatment success in studies, reducing both the inflammatory and non-inflammatory skin lesions we associate with acne,\" said Dr. Jerry Tan, MD, FRCPC, a dermatologist in Windsor, Ontario, and Adjunct Professor at Western University in London, Ontario. \"The convenient once-daily dosing of CABTREO will also be important to many patients.\"CABTREO will be made available through pharmacies across Canada in the fourth quarter this year.\"People with acne are always hopeful and excited when there is a new approved treatment in Canada that might help them,\" said Sue Sherlock, Executive Director of the Acne and Rosacea Society of Canada. \"Acne can significantly impact the emotional and social well-being of sufferers so having effective treatments is important to them.\"About Acne VulgarisAcne vulgaris (\"vulgaris\" means \"commo...